Corporate News     25-Apr-22
Board of Tatva Chintan Pharma Chem recommends Final Dividend
Of Rs.2 per share
Tatva Chintan Pharma Chem announced that the Board of Directors of the Company at its meeting held on 25 April 2022, has recommended a Final dividend of Rs.2 per share (i.e.20%), subject to the approval of the shareholders.
Previous News
  Tatva Chintan Pharma Chem AGM scheduled
 ( Corporate News - 28-Aug-24   14:54 )
  Tatva Chintan Pharma Chem consolidated net profit declines 70.22% in the December 2023 quarter
 ( Results - Announcements 20-Jan-24   16:38 )
  Tatva Chintan Pharma Chem to convene AGM
 ( Corporate News - 25-Aug-22   14:14 )
  Tatva Chintan Pharma Chem consolidated net profit declines 49.06% in the December 2022 quarter
 ( Results - Announcements 24-Jan-23   17:01 )
  Tatva Chintan Pharma hits 52-week low after reporting weak Q3 numbers
 ( Hot Pursuit - 23-Jan-24   11:17 )
  Tatva Chintan Pharma Chem IPO ends with robust subscription
 ( IPO Centre - IPO News 21-Jul-21   09:14 )
  Tatva Chintan Pharma hits record high after robust Q2 performance
 ( Hot Pursuit - 25-Oct-21   12:11 )
  Tatva Chintan Pharma Chem to convene board meeting
 ( Corporate News - 25-Apr-24   10:26 )
  Tatva Chintan Pharma reports weak numbers in Q3; PAT drops 70% YoY
 ( Hot Pursuit - 22-Jan-24   14:05 )
  Tatva Chintan Pharma Chem consolidated net profit rises 810.39% in the September 2021 quarter
 ( Results - Announcements 23-Oct-21   16:23 )
  Tatva Chintan Pharma Chem consolidated net profit declines 78.06% in the September 2022 quarter
 ( Results - Announcements 04-Nov-22   17:58 )
Other Stories
  GAIL (India) signs MoU with AM Green
  04-Oct-24   19:27
  EaseMyTrip.com resumes bookings to the Maldives
  04-Oct-24   19:25
  BLS completes acquisition of Dubai-based Citizenship Invest
  04-Oct-24   19:23
  Insecticides India launches new maize herbicide 'Torry Super'
  04-Oct-24   19:21
  Landmark Cars receives LoI from Mercedes-Benz India
  04-Oct-24   19:19
  Astra Microwave Products receives affirmation in credit ratings from CRISIL
  04-Oct-24   19:16
  Supreme Petrochem receives affirmation in credit ratings
  04-Oct-24   19:10
  Astec LifeSciences director resigns
  04-Oct-24   19:08
  Board of Gravita India approves change in directorate
  04-Oct-24   19:05
  Board of Gravita India approves fund raising up to Rs 1,000 cr
  04-Oct-24   19:03
Back Top